Pause of J&J vaccine was the suitable name, say 88% of polled People

A large streetside sign for a Johnson and Johnson vaccine.

Enlarge / Basic exterior view of the top workplace of Janssen pharmaceutical firm on April 15, 2021 in Leiden, Netherlands. (credit score: Getty | BSR Company)

About 88 p.c of People help the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not improve vaccine hesitancy, based on contemporary information from the Axios-Ipsos Coronavirus ballot.

The discovering is more likely to hearten public well being consultants, who’ve confronted criticism and concern that the pause may erode confidence in vaccine security and fortify already high-levels of vaccine hesitancy within the nation.

The Facilities for Illness Management and Prevention, together with the Meals and Drug Administration, beneficial a pause in the usage of the Johnson & Johnson vaccine on April 13 after linking the one-dose vaccine to 6 instances of a uncommon blood-clotting situation, one among which was deadly. The six instances occurred amongst greater than 6.eight million individuals given the vaccine, suggesting that if the blood clots are, in actual fact, a facet impact of the vaccine, they’re a particularly uncommon facet impact.

Learn 11 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published.